VSTM (Verastem Oncology) Gross Profit Margin

Corporate emblem and logo of Verastem Oncology (VSTM)

Verastem, Inc. (VSTM) ensures resilience through an asset-light model by outsourcing production to third-party contractors. This gross margin chart confirms this approach, where the 86.10 metric determines this level. The operational base relies on consistent demand in oncology that remains independent of economic cycles, while a neutral geopolitical status guarantees the protection of innovations from trade conflicts.

VSTM - verastem.com Return on Gross Profit over the range 07/04/2022 - 11/19/2026

Financial and market metric breakdowns for Verastem, Inc. (VSTM)

- share price and expert price forecast:
- business market valuation indicators:
Fundamental valuation:VSTM Verastem Oncology
Flagship merchandise of Verastem Corp

For a comparative asset analysis, the investor utilizes gross margin as a measure of operational efficiency, calculated by dividing the difference between revenue and cost of goods sold by total sales. The implementation of automated dispensers and software robots in the screening processes of Verastem, Inc. (VSTM) directly reduces variable costs, which is reflected in the current gross margin as an indicator of the business model's viability.